tocopherylquinone and Arteriosclerosis

tocopherylquinone has been researched along with Arteriosclerosis* in 3 studies

Trials

1 trial(s) available for tocopherylquinone and Arteriosclerosis

ArticleYear
Concentrations of alpha-tocopherol and its quinone derivative in cerebrospinal fluid from patients with vascular dementia of the Binswanger type and Alzheimer type dementia.
    Neuroscience letters, 1994, Jun-06, Volume: 174, Issue:1

    We determined the concentrations of alpha-tocopherol (alpha-TOH) and alpha-tocopherol quinone(alpha-TQ), an oxidized derivative of alpha-TOH, in cerebrospinal fluid from patients with Alzheimer type dementia (ATD) and those with vascular dementia of the Binswanger type (VDBT). Compared with results for the controls, the VDBT patients had unaltered concentrations of alpha-TOH, but a statistically significant, 3.6-fold increase of alpha-TQ (P < 0.01) which was significantly correlated with decreases in the Mini-Mental State Examination scores (P < 0.05). In contrast, ATD patients had significantly decreased concentrations of alpha-TOH (P < 0.01), but had unaltered concentrations of alpha-TQ. These results suggest that there is greater oxidation of alpha-TOH to alpha-TQ in VDBT brain, but are inconclusive about the occurrence of peroxidation in ATD brains.

    Topics: Aged; Aging; Alzheimer Disease; Arteriosclerosis; Dementia, Vascular; Humans; Lipid Peroxides; Psychiatric Status Rating Scales; Vitamin E

1994

Other Studies

2 other study(ies) available for tocopherylquinone and Arteriosclerosis

ArticleYear
Vitamin E oxidation in human atherosclerotic lesions.
    Circulation research, 2002, Feb-22, Volume: 90, Issue:3

    Oxidation of low-density lipoproteins (LDL) is a key process in atherogenesis, and vitamin E (alpha-tocopherol, TOH) has received attention for its potential to attenuate the disease. Despite this, the type and extent of TOH oxidation and its relationship to lipid oxidation in the vessel wall where lesions develop remain unknown. Therefore, we measured oxidized lipids, TOH, and its oxidation products, alpha-tocopherylquinone (TQ), 2,3- and 5,6-epoxy-alpha-tocopherylquinones by gas chromatography-mass spectrometry analysis in human lesions representing different stages of atherosclerosis. We also oxidized LDL in vitro to establish "footprints" of TOH oxidation product for different oxidants. The in vitro studies demonstrated that tocopherylquinone epoxides are the major products when LDL is exposed to the one-electron (ie, radical) oxidants, peroxyl radicals, and copper ions, whereas TQ preferentially accumulates with the two-electron (nonradical) oxidants, hypochlorite, and peroxynitrite. In human lesions, the relative extent of TOH oxidation was maximal early in the disease where it exceeded lipid oxidation. Independent of the disease stage, TQ was always the major oxidation product with all products together representing <20% of the total TOH present, and the oxidation product profile mirroring that formed during LDL oxidation by activated monocytes in the presence of nitrite. In contrast, oxidized lipid increased with increasing disease severity. These results suggest that two-electron oxidants are primarily responsible for TOH oxidation in the artery wall, and that the extent of TOH oxidation is limited yet substantial lipid oxidation takes place. This study may have important implications regarding antioxidant supplements aimed at preventing LDL oxidation and hence atherogenesis.

    Topics: Adult; Aorta; Arteriosclerosis; Carotid Arteries; Chlorides; Female; Gas Chromatography-Mass Spectrometry; Humans; Lipoproteins, LDL; Male; Middle Aged; Monocytes; Nitrites; Oxidants; Oxidation-Reduction; Tetradecanoylphorbol Acetate; Vitamin E

2002
[ACTION OF TOCOPHERYLQUINONE IN ARTERIAL HYPERTENSION OF THE FIFTIES].
    Toulouse medical, 1963, Volume: 64

    Topics: Antihypertensive Agents; Arteriosclerosis; Geriatrics; Humans; Hypertension; Middle Aged; Quinones; Vitamin E

1963